| Athena Kartsaklis |
Athena Kartsaklis is currently the Director at Variation Biotechnologies, Inc. (Canada), the Senior Vice President-Finance at SkyWave Mobile Communications, Inc., and the Senior Vice President-Finance at VBI Vaccines, Inc. Previously, she worked as a Partner at Deloitte Certified Public Accountants SA from 2000 to 2012. Ms. Kartsaklis completed her undergraduate degree at Dalhousie University. |
| Misha Nossov |
Misha Nossov is currently working as the Senior VP-Global Commercial Supply Strategy at VBI Vaccines, Inc. He completed his undergraduate degree at McGill University in 2008 and his graduate degree at the University of Toronto in 2010. |
| Nell Beattie |
Nell Beattie is currently working as the CFO, Director & Head-Business Development at VBI Vaccines, Inc. She started this position in 2023. Prior to her current role, she obtained an undergraduate degree from Dartmouth College in 2009. She then pursued an MBA from the Tuck School of Business at Dartmouth, which she completed in 2015. |
| John Dillman |
John Dillman is currently the Chief Commercial Officer at VBI Vaccines, Inc. and also holds a current position as Commercial Lead at Syneos Health, Inc. Prior to his current roles, he worked as a Director at Healthcare Distribution Alliance, Vice President-Sales at Sanofi Pasteur, Inc., and General Manager at VaxServe, Inc. from 2009 to 2012. Mr. Dillman has an undergraduate degree from Bridgewater State College and an MBA from West Virginia University. |
| David Evander Anderson |
David Evander Anderson was the founder of Variation Biotechnologies (US), Inc. founded in 2001 where he held the title of Vice President-Immunology & Research. He is also the founder of Variation Biotechnologies, Inc. (Canada). Currently, Dr. Anderson holds the position of Chief Scientific Officer at VBI Vaccines, Inc. since 2016 and at VBI Vaccines (Delaware), Inc. since 2015. Previously, he worked as an Assistant Professor at Harvard Medical School in 2009 and as the Chief Scientific Officer & Senior VP-Research at VBI Vaccines, Inc. Dr. Anderson received his doctorate degree from Harvard University in 1999 and his undergraduate degree from the University of California, Davis. |
| Francisco Diaz-Mitoma |
Francisco Diaz-Mitoma is the founder of Childrens Hospital of Eastern Ontario Research Institute, Inc. (1990), Variation Biotechnologies (US), Inc. (2001), Health Sciences North Research Institute (2011), and Bowhead Health, Inc. (2016). He is currently the Director at Vaccine & Infectious Disease Organization (since 2022), Chief Medical Officer at VBI Vaccines, Inc. (since 2016), and President at F. Diaz-Mitoma Profesional Corp. (former job). Dr. Diaz-Mitoma holds a doctorate degree from the University of Alberta (1989) and the University of Guadalajara. |
| Steven H. Gillis |
Steven H. Gillis founded Immunex Corp. in 1981, where he worked as Director, Chief Executive & Scientific Officer from 1981 to 1994 and Corixa Corp. in 1994, where he worked as Chairman & Chief Executive Officer from 1999 to 2005. Dr. Gillis also currently works at Theraclone Sciences, Inc., as Chairman from 2011, Codiak BioSciences, Inc., as Chairman from 2015, VBI Vaccines, Inc., as Chairman from 2016, and various other companies. Dr. Gillis also formerly worked at Emergent Product Development Seattle, as Executive Chairman, President & CEO from 2009 to 2010, Allozyne, Inc., as Executive Chairman, Viral Logic Systems Technology Corp., as Chairman in 2009, and various other companies. Dr. Gillis received his doctorate degree in 1978 from Dartmouth College and undergraduate degree in 1975 from Williams College. |
| Jeffrey R. Baxter |
Jeffrey R. Baxter is currently the President, Chief Executive Officer & Director at Variation Biotechnologies (US), Inc., VBI Vaccines, Inc., and VBI Vaccines (Delaware), Inc. He previously served as an Independent Non-Executive Director at Chromadex Corp. from 2015 to 2022. Baxter also held positions at GSK Plc as SVP-Research & Development Finance from 2002 to 2006 and as a Managing Partner at The Column Group LLC. He received his undergraduate degree from the University of West London. Baxter also worked as a Principal at British American Tobacco plc and Unilever Plc. |
| Vaughn B. Himes |
Vaughn B. Himes is an Independent Director at VBI Vaccines, Inc. and Achieve Life Sciences, Inc. He previously held positions as Associate Director-Biological Development at Wyeth Lederle Vaccines SA, Vice President-Manufacturing Operations at AmpliPhi Biosciences Corp., Vice President-Worldwide Manufacturing at Corixa Corp., Chief Technical Officer at Seagen Inc., Senior Vice President-Technical Operations at ZymoGenetics, Inc., and Vice President-Product Development at Genovo, Inc. Himes received his undergraduate degree from Pomona College and his doctorate from the University of Minnesota. |
| Joanne Cordeiro |
Joanne Cordeiro is an Independent Director at VBI Vaccines, Inc. She was previously the Chief Human Resources Officer & Executive VP-HR at Shire Plc from 2017 to 2019. Prior to that, she was the Head-Human Resources at Covansys Corp. in 2000. She also served as the Head-Human Resources at Availant, Inc. Ms. Cordeiro completed her undergraduate degree at Northeastern University. |
| Blaine H. McKee |
Blaine H. McKee is currently the President & Chief Executive Officer at Walden Biosciences, Inc. He is also a Director at OrbiMed Israel Partners LP and an Independent Director at VBI Vaccines, Inc. Previously, he held positions such as Director at ArmaGen, Inc., Independent Director at Harvard Apparatus Regenerative Technology, Inc., Director at New York Pharma Forum, Inc., Chief Business Officer & Executive Vice President at ImmunoGen, Inc., Senior Vice President-Strategic Development at Genzyme Corp., Senior VP & Head-Corporate Development at Shire Plc, and Chief Business Officer & Executive Vice President at Lyra Therapeutics, Inc. Dr. McKee received his doctorate from Massachusetts Institute of Technology, his undergraduate degree from Colorado State University, and his MBA from MIT Sloan School of Management. |
| Michel de Wilde |
Michel de Wilde is currently an Independent Director at VBI Vaccines, Inc., a Director at VBI Vaccines (Delaware), Inc., and a Director at Verband Beratender Ingenieure VBI. He was formerly a Director at Infectious Disease Research Institute from 2014 to 2019, an Independent Director at VBI Vaccines, Inc., and a Senior Vice President-Research & Development at Sanofi Pasteur, Inc. from 2001 to 2013. He received a doctorate degree from Université Libre de Bruxelles in 1976 and an undergraduate degree from the same institution in 1971. |
| Damian Braga |
Damian Braga is the founder of DAB Consulting Services LLC, which was founded in 2015. He is currently an Independent Director at VBI Vaccines, Inc. since 2020 and President at Topaz Pharmaceuticals, Inc. He was previously a Director at Life Sciences Greenhouse of Central Pennsylvania. Mr. Braga worked at Sanofi Pasteur, Inc. from 1988 to 2015, where he held the position of President-US & SVP-Global Commercial Operations from 2010 to 2015. He was also Senior Vice President-Global Commercial Operation at Sanofi Pasteur Americas from 2002 to 2015. Mr. Braga holds an MBA from Seton Hall University and an undergraduate degree from the University of Miami. |
